Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Mologen AG
DescriptionLinear DNA-based toll-like receptor 9 (TLR9) agonist
Molecular Target Toll-like receptor 9 (TLR9)
Mechanism of ActionImmune modulation; Toll-like receptor 9 (TLR9) agonist
Therapeutic ModalityNucleic acid: Linear DNA
Latest Stage of DevelopmentPreclinical
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today